{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:39:06Z","timestamp":1770356346314,"version":"3.49.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008052","name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cjco.2020.11.022","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T19:04:19Z","timestamp":1609009459000},"page":"532-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review"],"prefix":"10.1016","volume":"3","author":[{"given":"Sylvain","family":"Lemay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montse","family":"Massot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Philippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Belzile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Yves","family":"Turgeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Lalibert\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Dion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Milot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika\u00ebl","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Gosselin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Charbonneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"S\u00e9n\u00e9chal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2020.11.022_bib1","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib3","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1183\/09031936.00197808","article-title":"Prevalence of sarcoidosis in Switzerland is associated with environmental factors","volume":"35","author":"Deubelbeiss","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjco.2020.11.022_bib6","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.11.022_bib7","first-page":"377","article-title":"Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.cjco.2020.11.022_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.11.022_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2020.11.022_bib13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib15","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstrom","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","article-title":"Cardiac sarcoidosis","volume":"157","author":"Kim","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1376889","article-title":"Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment","volume":"35","author":"Lynch","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib21","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cjco.2020.11.022_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0002-8703(79)90004-8","article-title":"Sarcoidosis of the cardiac conducting system","volume":"97","author":"Abeler","year":"1979","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","volume":"37","author":"Nery","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib25","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/europace\/eul173","article-title":"Sarcoidosis presenting with tachy- and brady-arrhythmias","volume":"9","author":"Swanson","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2020.11.022_bib28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1540-8167.2009.01479.x","article-title":"Sarcoid myocarditis with ventricular tachycardia mimicking ARVD\/C","volume":"21","author":"Ladyjanskaia","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/pace.12626","article-title":"Pleomorphism during ventricular tachycardia: a distinguishing feature between cardiac sarcoidosis and idiopathic VT","volume":"38","author":"Panda","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib31","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1378\/chest.11-3214","article-title":"Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications","volume":"143","author":"Viles-Gonzalez","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.hlc.2014.07.065","article-title":"Evaluation and management of heart rhythm disturbances due to cardiac sarcoidosis","volume":"23","author":"Selan","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cjco.2020.11.022_bib33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjcard.2013.11.015","article-title":"Morphologic features of cardiac sarcoidosis in native hearts of patients having cardiac transplantation","volume":"113","author":"Roberts","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.carpath.2013.06.005","article-title":"Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device","volume":"23","author":"Segura","year":"2014","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjco.2020.11.022_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","article-title":"A\u00a0clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis","volume":"41","author":"Okura","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib36","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis- digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.cjco.2020.11.022_bib37","first-page":"75","article-title":"Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis","volume":"16","author":"Judson","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cjco.2020.11.022_bib38","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cjco.2020.11.022_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib40","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib41","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1183\/09031936.06.00112205","article-title":"Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients","volume":"27","author":"Muller-Quernheim","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cjco.2020.11.022_bib42","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1253\/circj.71.1937","article-title":"Cardiac sarcoidosis underlies idiopathic dilated cardiomyopathy: importance of mediastinal lymphadenopathy in differential diagnosis","volume":"71","author":"Otsuka","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.cjco.2020.11.022_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/ehjci\/jex340","article-title":"Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis","volume":"19","author":"Wicks","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib44","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chest.2017.10.014","article-title":"Clinical course of sarcoidosis in World Trade Center-exposed firefighters","volume":"153","author":"Hena","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","volume":"18","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib47","first-page":"18","article-title":"Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations","volume":"36","author":"Russo","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cjco.2020.11.022_bib48","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.rmed.2018.09.008","article-title":"Cardiac sarcoidosis: diagnosis confirmation by bronchoalveolar lavage and lung biopsy","volume":"144S","author":"Petek","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib49","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","article-title":"Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement","volume":"22","author":"Schuller","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1378\/chest.11-0263","article-title":"Management of cardiac sarcoidosis in the United States: a Delphi study","volume":"141","author":"Hamzeh","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2015.03.175","article-title":"Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis","volume":"189","author":"Nagao","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib52","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1542-474X.2010.00411.x","article-title":"Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis","volume":"16","author":"Schuller","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib54","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.hrthm.2015.09.008","article-title":"QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis","volume":"12","author":"Sobue","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-8703(85)90524-1","article-title":"Echocardiographic evaluation of patients with systemic sarcoidosis","volume":"110","author":"Lewin","year":"1985","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11886-018-1065-9","article-title":"Echocardiography in sarcoidosis","volume":"20","author":"Kurmann","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cjco.2020.11.022_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/17476348.2018.1511431","article-title":"Cardiac sarcoidosis - an expert review for the chest physician","volume":"13","author":"Ho","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9149(89)90323-8","article-title":"Two-dimensional echocardiographic findings in systemic sarcoidosis","volume":"63","author":"Burstow","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11886-015-0572-1","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"17","author":"Ayoub","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cjco.2020.11.022_bib60","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/echo.13281","article-title":"Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction","volume":"33","author":"Murtagh","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjco.2020.11.022_bib61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijcard.2016.10.073","article-title":"Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography","volume":"227","author":"Schouver","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib62","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s11936-012-0208-3","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"14","author":"Bussinguer","year":"2012","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib63","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00296-009-0904-9","article-title":"Assessment of cardiac involvement in sarcoidosis by echocardiography","volume":"29","author":"Focardi","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cjco.2020.11.022_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"suppl 1","key":"10.1016\/j.cjco.2020.11.022_bib65","first-page":"S52","article-title":"Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis","volume":"68","author":"Angomachalelis","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cjco.2020.11.022_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2020.11.022_bib67","first-page":"7457369","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"key":"10.1016\/j.cjco.2020.11.022_bib68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.112.115121","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib69","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jmri.24196","article-title":"Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis","volume":"39","author":"Yang","year":"2014","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00015385.2017.1325633","article-title":"Cardiac sarcoidosis: a diagnostic and therapeutic challenge","volume":"73","author":"Timmers","year":"2018","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib71","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1136\/hrt.2011.226076","article-title":"Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment","volume":"97","author":"Youssef","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2020.11.022_bib72","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2214\/ajr.185.1.01850110","article-title":"Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging","volume":"185","author":"Tadamura","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cjco.2020.11.022_bib73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/postgradmedj-2014-133219","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"91","author":"Dubrey","year":"2015","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cjco.2020.11.022_bib74","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.ijcard.2014.07.157","article-title":"Cardiac magnetic resonance imaging for assessment of steroid therapy in a patient with cardiac sarcoidosis and a magnetic resonance-conditional pacemaker","volume":"176","author":"Kono","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib75","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2967\/jnumed.110.076232","article-title":"Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques","volume":"51","author":"Gotthardt","year":"2010","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib77","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cjco.2020.11.022_bib78","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib79","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib80","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","article-title":"Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis","volume":"195","author":"Yokoyama","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib82","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","article-title":"Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis","volume":"95","author":"Chiu","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib84","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cardfail.2019.02.018","article-title":"Serial cardiac FDG-PET for the diagnosis and therapeutic guidance of patients with cardiac sarcoidosis","volume":"25","author":"Ning","year":"2019","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjco.2020.11.022_bib86","first-page":"1","article-title":"The use of serial cardiac (18)F-fluorodeoxyglucose positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and review","volume":"3","author":"Kersey","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.cjco.2020.11.022_bib87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib88","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s12350-018-01504-y","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","volume":"27","author":"Flores","year":"2020","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib89","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib90","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib93","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2020.11.022_bib94","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1378\/chest.104.2.352","article-title":"Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis","volume":"104","author":"Winterbauer","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib95","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/resp.13537","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: beyond the diagnostic yield","volume":"24","author":"Trisolini","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.cjco.2020.11.022_bib96","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib97","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.cjco.2020.11.022_bib98","first-page":"320","article-title":"Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis","volume":"62","author":"Yodogawa","year":"2013","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib99","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib100","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10554-005-9043-x","article-title":"Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia","volume":"22","author":"Futamatsu","year":"2006","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2020.11.022_bib101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","article-title":"Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry","volume":"6","author":"Jefic","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib102","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis; insights from implantable cardioverter defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib103","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib104","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.cjco.2020.11.022_bib105","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s10067-007-0614-1","article-title":"Cardiac sarcoidosis responding to monotherapy with infliximab","volume":"26","author":"Uthman","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cjco.2020.11.022_bib106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jccase.2015.12.008","article-title":"Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis","volume":"13","author":"Kikuchi","year":"2016","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.cjco.2020.11.022_bib107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/kev309","article-title":"Successful use of rituximab in refractory cardiac sarcoidosis","volume":"55","author":"Krause","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cjco.2020.11.022_bib108","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.94.1.202","article-title":"Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide","volume":"94","author":"Demeter","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.cjco.2020.11.022_bib109","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib110","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib111","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","article-title":"Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis","volume":"117","author":"Nagai","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib112","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.cjco.2020.11.022_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.cjco.2020.11.022_bib114","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006685","article-title":"Which patients with cardiac sarcoidosis should receive implantable cardioverter-defibrillators: some answers but many questions remain","volume":"11","author":"Birnie","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.cjco.2020.11.022_bib116","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2020.11.022_bib117","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2020.11.022_bib118","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007488","article-title":"Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable cardioverter-defibrillator implantation in cardiac sarcoidosis","volume":"12","author":"Kazmirczak","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib119","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","article-title":"Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis","volume":"96","author":"Aizer","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib121","first-page":"210","article-title":"Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis","volume":"22","author":"Stees","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib122","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib123","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9149(98)00377-4","article-title":"Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy","volume":"82","author":"Yazaki","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib124","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jacc.2018.01.016","article-title":"Spectrum of restrictive and infiltrative cardiomyopathies: part 1 of a 2-part series","volume":"71","author":"Pereira","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib125","first-page":"2663","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2020.11.022_bib126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jce.13119","article-title":"Outcome of patients with cardiac sarcoidosis who received cardiac resynchronization therapy: comparison with dilated cardiomyopathy patients","volume":"28","author":"Yufu","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjco.2020.11.022_bib127","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardfail.2018.02.009","article-title":"A\u00a0contemporary analysis of heart transplantation and bridge-to-transplant mechanical circulatory support outcomes in cardiac sarcoidosis","volume":"24","author":"Crawford","year":"2018","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjco.2020.11.022_bib128","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","article-title":"Recurrence of cardiac sarcoidosis in a heart transplant recipient","volume":"24","author":"Yager","year":"2005","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2020.11.022_bib129","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2013.02.116","article-title":"Heart transplantation for end-stage heart failure due to cardiac sarcoidosis","volume":"45","author":"Perkel","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cjco.2020.11.022_bib130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2015.12.005","article-title":"Insights into biopsy-proven cardiac sarcoidosis in patients with heart failure","volume":"35","author":"Sperry","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.cjco.2020.11.022_bib131","first-page":"208","article-title":"Heart transplantation for advanced heart failure due to cardiac sarcoidosis","volume":"32","author":"Theofilogiannakos","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cjco.2020.11.022_bib132","first-page":"367","article-title":"Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids","volume":"11","author":"Oni","year":"1992","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X20302353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X20302353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:04:21Z","timestamp":1762902261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X20302353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589790X20302353"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2020.11.022","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten Questions Cardiologists Should Be Able to Answer About Cardiac Sarcoidosis: Case-Based Approach and Contemporary Review","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2020.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Cardiovascular Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}